225 related articles for article (PubMed ID: 12557810)
1. Soy foods and soybean isoflavones and menopausal health.
Messina MJ
Nutr Clin Care; 2002; 5(6):272-82. PubMed ID: 12557810
[TBL] [Abstract][Full Text] [Related]
2. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
3. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
5. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S; Strickman-Stein N; Doerge DR; Krischer J
Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones as safe functional ingredients.
Song WO; Chun OK; Hwang I; Shin HS; Kim BG; Kim KS; Lee SY; Shin D; Lee SG
J Med Food; 2007 Dec; 10(4):571-80. PubMed ID: 18158825
[TBL] [Abstract][Full Text] [Related]
7. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones: are they useful in menopause?
Vincent A; Fitzpatrick LA
Mayo Clin Proc; 2000 Nov; 75(11):1174-84. PubMed ID: 11075748
[TBL] [Abstract][Full Text] [Related]
9. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
[TBL] [Abstract][Full Text] [Related]
11. Soy foods, isoflavones, and the health of postmenopausal women.
Messina M
Am J Clin Nutr; 2014 Jul; 100 Suppl 1():423S-30S. PubMed ID: 24898224
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.
Levis S; Strickman-Stein N; Ganjei-Azar P; Xu P; Doerge DR; Krischer J
Arch Intern Med; 2011 Aug; 171(15):1363-9. PubMed ID: 21824950
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview.
Chen LR; Chen KH
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809928
[TBL] [Abstract][Full Text] [Related]
15. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy--clinical implications.
Ravn SH; Rosenberg J; Bostofte E
Eur J Obstet Gynecol Reprod Biol; 1994 Feb; 53(2):81-93. PubMed ID: 8194655
[TBL] [Abstract][Full Text] [Related]
18. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
[TBL] [Abstract][Full Text] [Related]
19. Soy and its isoflavones: a review of their effects on bone density.
Brynin R
Altern Med Rev; 2002 Aug; 7(4):317-27. PubMed ID: 12197783
[TBL] [Abstract][Full Text] [Related]
20. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
